SUSAN MCCULLOUGH: Open Payments
NPI 1518583129 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 117 payments from 19 companies in 2025. Trend: 2023 $1,193 · 2024 $1,917 · 2025 $1,988
Food & beverage: $1,988
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $347 |
| Lilly USA, LLC | 19 | $278 |
| AstraZeneca Pharmaceuticals LP | 12 | $267 |
| Novo Nordisk Inc | 13 | $252 |
| PFIZER INC. | 14 | $174 |
| Amgen Inc. | 9 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $151 |
| Phathom Pharmaceuticals, Inc. | 6 | $62 |
| Dexcom, Inc. | 2 | $49 |
| Boston Scientific Corporation | 2 | $48 |
Products named: LINZESS, MOUNJARO, NURTEC ODT, Kerendia, UBRELVY, Ozempic, OTEZLA, FARXIGA.
Industry payments across MS — which companies pay providers there.
